ETROLIZUMAB COMPARED WITH ADALIMUMAB OR PLACEBO AS INDUCTION THERAPY FOR ULCERATIVE COLITIS: RESULTS FROM THE RANDOMIZED, PHASE 3 HIBISCUS I & II TRIALS

Iris Dotan  1     Julian Panés  2     Aaron Duvall  3     Yoram Bouhnik  4     Graham Radford-Smith  5     Peter D.R. Higgins  6     Daniel S. Mishkin  7     Pablo Arrisi     Astrid Scalori     Young Oh     Swati Tole     Akiko Chai     Kirsten Chamberlain-James     Stuart Lacey     Jacqueline McBride     David T. Rubin    
1 Rabin Medical Center,Petah Tikva,Israel
2 Hospital Clinic Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 Tyler Research Institute,Tyler,United States
4 Inserm et Université Paris Diderot,Paris,France
5 Royal Brisbane and Women’s Hospital,Herston,Australia
6 University of Michigan,Ann Arbor,United States
7 Atrius Health,Boston,United States

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing